药物性肝损伤1例

2018-02-01 佚名 临床肝胆病杂志

患者女性,86岁

【一般资料】

患者女性,86岁

【主诉】

因“尿黄1周”于2016年10月26日以“肝功能异常”收入本院疑难肝病及人工肝中心。

【现病史】

1周前患者自觉小便颜色加深,无纳差、乏力、恶心、呕吐、腹胀等不适,大便颜色正常。查体:生命体征平稳,神志清,精神可,皮肤及巩膜轻度黄染,肝掌及蜘蛛痣阴性,心肺听诊无异常。腹部查体未见阳性体征,双下肢无水肿。既往“冠心病”病史10余年,“皮肤湿疹”病史5年,间断应用中药治疗,曾因服用含有首乌藤的中药致肝功能异常,后治愈。起病前10d患者应用含有白藓皮的中药治疗湿疹。

【既往史】

既往否认乙型肝炎、丙型肝炎等慢病肝病史,否认长期大量饮酒及不洁饮食史。

【辅助检查】

血常规:嗜酸粒细胞0.77×109/L(正常值:0.02~0.52×10^9/L),余未见明显异常;肝功能:ALT1525.1U/L,AST1234.3U/L,TBil51.5μmol/L,DBil22.5μmol/L,GGT57.9U/L,ALP162.2U/L;凝血功能:PT12.5s,PTA85%。肝炎病毒、EB病毒以及巨细胞病毒标志物均为阴性,自身抗体均为阴性。腹部超声示:弥漫性肝病表现,肝内胆管未见扩张。结合中华医学会肝病学分会药物性肝病学组提出的《药物性肝损伤诊治指南》,考虑到患者起病前曾有明确的肝损伤药物(白藓皮)使用史,结合相关实验室检查,排除其他肝病,药物性肝损伤因果关系评估为10分。

【初步诊断

药物性肝损伤,急性,肝细胞损伤型,RUCAM:10分。

【治疗】

入院后嘱患者停用中药治疗湿疹,给予复方甘草酸酐、还原型谷胱甘肽、多烯磷脂酰胆碱保肝治疗。2016年10月31日复查肝功能:ALT400.4U/L,AST563.3U/L,较前明显下降,但胆红素较前有升高,TBil81.1μmol/L,DBil55.9μmol/L。后加用口服熊去氧胆酸胶囊,静脉给予前列地尔药物治疗。2016年11月4日复查,转氨酶继续下降,但胆红素仍进行性升高(TBil138.2μmol/L,DBil89.8μmol/L)。2016年11月5日起给予应用甲强龙注射液40mg/d-20mg/d-20mg/d,共3d,以期达到顿挫病情的目的。但2016年11月8日复查结果示:转氨酶继续下降,TBil升至185.1μmol/L,DBil142μmol/L。2016年11月8日加用思美泰治疗。2016年11月14日TBil升至204.8μmol/L,DBil145μmol/L,复查凝血功能正常,血常规:白细胞计数9.59×10^9/L,中性粒细胞百分比为64.8%。完善肝脏MRI示:肝脏未见明显异常。此时决定加用低分子肝素0.6ml皮下注射,头孢唑肟注射液2.0g,1次/12h,静脉输注抗感染治疗。治疗1周后复查肝功能示:TBil降至87.4μmol/L,DBil63.5μmol/L,胆汁淤积减轻。应用抗生素及低分子肝素治疗1周后停药,复查肝功能,胆红素继续下降。于2016年11月26日好转出院,出院后继续给予口服保肝药物治疗。具体病程中的肝功能指标变化见表1。


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=285781, encodeId=d4f1285e81c7, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Tue Feb 06 23:55:16 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338778, encodeId=38211338e7892, content=<a href='/topic/show?id=9d3d812280b' target=_blank style='color:#2F92EE;'>#肝损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81228, encryptionId=9d3d812280b, topicName=肝损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397461, encodeId=e9a9139e46192, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540069, encodeId=0579154006912, content=<a href='/topic/show?id=52f28e736c9' target=_blank style='color:#2F92EE;'>#药物性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87736, encryptionId=52f28e736c9, topicName=药物性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55e413178317, createdName=yangfl10, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284514, encodeId=e74028451454, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 02 19:18:41 CST 2018, time=2018-02-02, status=1, ipAttribution=)]
    2018-02-06 天涯183

    非常好的文章.学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=285781, encodeId=d4f1285e81c7, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Tue Feb 06 23:55:16 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338778, encodeId=38211338e7892, content=<a href='/topic/show?id=9d3d812280b' target=_blank style='color:#2F92EE;'>#肝损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81228, encryptionId=9d3d812280b, topicName=肝损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397461, encodeId=e9a9139e46192, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540069, encodeId=0579154006912, content=<a href='/topic/show?id=52f28e736c9' target=_blank style='color:#2F92EE;'>#药物性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87736, encryptionId=52f28e736c9, topicName=药物性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55e413178317, createdName=yangfl10, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284514, encodeId=e74028451454, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 02 19:18:41 CST 2018, time=2018-02-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=285781, encodeId=d4f1285e81c7, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Tue Feb 06 23:55:16 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338778, encodeId=38211338e7892, content=<a href='/topic/show?id=9d3d812280b' target=_blank style='color:#2F92EE;'>#肝损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81228, encryptionId=9d3d812280b, topicName=肝损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397461, encodeId=e9a9139e46192, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540069, encodeId=0579154006912, content=<a href='/topic/show?id=52f28e736c9' target=_blank style='color:#2F92EE;'>#药物性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87736, encryptionId=52f28e736c9, topicName=药物性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55e413178317, createdName=yangfl10, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284514, encodeId=e74028451454, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 02 19:18:41 CST 2018, time=2018-02-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=285781, encodeId=d4f1285e81c7, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Tue Feb 06 23:55:16 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338778, encodeId=38211338e7892, content=<a href='/topic/show?id=9d3d812280b' target=_blank style='color:#2F92EE;'>#肝损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81228, encryptionId=9d3d812280b, topicName=肝损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397461, encodeId=e9a9139e46192, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540069, encodeId=0579154006912, content=<a href='/topic/show?id=52f28e736c9' target=_blank style='color:#2F92EE;'>#药物性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87736, encryptionId=52f28e736c9, topicName=药物性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55e413178317, createdName=yangfl10, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284514, encodeId=e74028451454, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 02 19:18:41 CST 2018, time=2018-02-02, status=1, ipAttribution=)]
    2018-02-03 yangfl10
  5. [GetPortalCommentsPageByObjectIdResponse(id=285781, encodeId=d4f1285e81c7, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Tue Feb 06 23:55:16 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338778, encodeId=38211338e7892, content=<a href='/topic/show?id=9d3d812280b' target=_blank style='color:#2F92EE;'>#肝损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81228, encryptionId=9d3d812280b, topicName=肝损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397461, encodeId=e9a9139e46192, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540069, encodeId=0579154006912, content=<a href='/topic/show?id=52f28e736c9' target=_blank style='color:#2F92EE;'>#药物性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87736, encryptionId=52f28e736c9, topicName=药物性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55e413178317, createdName=yangfl10, createdTime=Sat Feb 03 08:07:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284514, encodeId=e74028451454, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 02 19:18:41 CST 2018, time=2018-02-02, status=1, ipAttribution=)]
    2018-02-02 131****1460

    学习了受益匪浅

    0

相关资讯

JCI Insight:过度酒精消耗引起mtDNA富集MPs的释放导致中性粒细胞增多和肝损伤

在过去的几年中,酒精性肝病研究领域的一个重大进展便是发现慢性乙醇喂养的小鼠和过度饮酒人中,过度酒精消耗 (EAU)可诱导中性粒细胞增多和肝中性粒细胞浸润,然而,这种现象潜在的机制仍不清楚。该研究表明,慢性 EAU患者若存在近期过度饮酒史(EAU+ RD),其血清线粒体DNA(mtDNA)富集微粒(MPs)的水平较EAU无近期饮酒史(EAU–RD)及健康对照组高,这与循环中性粒细胞呈正相关。相似地,

复方酮康唑发用洗剂含激素,药监局警告其副作用!

9月8日,国家食品药品监督管理总局发布公告:

抗结核病药致肝损,如何防治?

抗结核病药能抑制或杀灭结核杆菌,其中一线药有异烟肼、利福平、乙胺丁醇、链霉素、吡嗪酰胺等。在抗结核治疗过程中可能会出现各种不同程度的药物不良反应,其中以药物性肝损伤(DILI)最为多见,危害性最大,轻者表现为一过性转氨酶升高,重者可致肝衰竭,甚至危及生命,部分患者因此不得不中止抗结核治疗,从而影响结核病的治疗效果。一项研究表明我国抗结核药所致 DILI发生率为 2.55%。以下内容根据《抗结核药所

当抗甲状腺药物造成肝损伤时 如何改善甲亢症状?

Graves病(GD)是一种伴甲状腺激素(TH)分泌增多的器官特异性自身免疫疾病,临床表现并不限于甲状腺,而是一种多系统的综合征,包括:高代谢症群、弥漫性甲状腺肿、眼征、皮损等症状。通过学习此病例我们将会更好的了解Graves病、甲亢的常见病因及GD的发病机制等

动物实验显示“三手烟”导致肝损伤和糖尿病

新华社北京9月18日电 美国科学家通过动物实验发现,通过衣物、家具等接触“三手烟”,会增加实验鼠出现肝损伤和糖尿病等疾病的风险。

J Gastroen Hepatol:三丁酸甘油酯预防酒精导致的慢性肠黏膜和肝损伤

三丁酸甘油酯补充可减轻酒精对肠道紧密连接蛋白的影响,改善肠道通透性和肝损伤